IRIS Accounts Production v23.1.5.20 08019500 Board of Directors Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false Ordinary 1.00000 Class 'A' Redeemable 1.00000 Class 'B' Redeemable 1.00000 Class 'C' Redeemable 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080195002022-03-31080195002023-03-31080195002022-04-012023-03-31080195002021-03-31080195002021-04-012022-03-31080195002022-03-3108019500ns15:EnglandWales2022-04-012023-03-3108019500ns14:PoundSterling2022-04-012023-03-3108019500ns10:Director12022-04-012023-03-3108019500ns10:Director22022-04-012023-03-3108019500ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3108019500ns10:SmallEntities2022-04-012023-03-3108019500ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3108019500ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3108019500ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3108019500ns10:FullAccounts2022-04-012023-03-310801950012022-04-012023-03-3108019500ns10:OrdinaryShareClass12022-04-012023-03-3108019500ns10:OrdinaryShareClass22022-04-012023-03-3108019500ns10:OrdinaryShareClass32022-04-012023-03-3108019500ns10:OrdinaryShareClass42022-04-012023-03-3108019500ns10:Director32022-04-012023-03-3108019500ns10:Director42022-04-012023-03-3108019500ns10:RegisteredOffice2022-04-012023-03-3108019500ns5:CurrentFinancialInstruments2023-03-3108019500ns5:CurrentFinancialInstruments2022-03-3108019500ns5:ShareCapital2023-03-3108019500ns5:ShareCapital2022-03-3108019500ns5:RetainedEarningsAccumulatedLosses2023-03-3108019500ns5:RetainedEarningsAccumulatedLosses2022-03-3108019500ns5:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108019500ns5:PatentsTrademarksLicencesConcessionsSimilar2022-04-012023-03-3108019500ns5:PlantMachinery2022-04-012023-03-3108019500ns5:FurnitureFittings2022-04-012023-03-3108019500ns5:ComputerEquipment2022-04-012023-03-3108019500ns5:IntangibleAssetsOtherThanGoodwill2022-03-3108019500ns5:IntangibleAssetsOtherThanGoodwill2023-03-3108019500ns5:IntangibleAssetsOtherThanGoodwill2022-03-3108019500ns5:PlantMachinery2022-03-3108019500ns5:PlantMachinery2023-03-3108019500ns5:PlantMachinery2022-03-3108019500ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3108019500ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3108019500ns10:OrdinaryShareClass12023-03-3108019500ns10:OrdinaryShareClass22023-03-3108019500ns10:OrdinaryShareClass32023-03-3108019500ns10:OrdinaryShareClass42023-03-31
REGISTERED NUMBER: 08019500 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

FOR

LASE MEDICAL LIMITED

LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LASE MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTORS: A Ali-Khan
L Ali-Khan





REGISTERED OFFICE: Haughmond House
Aykley Heads Farm
Durham
DH1 5AN





REGISTERED NUMBER: 08019500 (England and Wales)





ACCOUNTANTS: Ribchesters
Chartered Accountants
Finchale House
Belmont Business Park
Durham
DH1 1TW

LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,150 1,346
Tangible assets 5 198 110
1,348 1,456

CURRENT ASSETS
Debtors 6 215,786 142,016
Cash at bank 14,140 12,146
229,926 154,162
CREDITORS
Amounts falling due within one year 7 128,566 108,612
NET CURRENT ASSETS 101,360 45,550
TOTAL ASSETS LESS CURRENT
LIABILITIES

102,708

47,006

PROVISIONS FOR LIABILITIES 337 364
NET ASSETS 102,371 46,642

CAPITAL AND RESERVES
Called up share capital 8 5 5
Retained earnings 102,366 46,637
SHAREHOLDERS' FUNDS 102,371 46,642

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)

BALANCE SHEET - continued
31 MARCH 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 October 2023 and were signed on its behalf by:




A Ali-Khan - Director



L Ali-Khan - Director


LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. STATUTORY INFORMATION

LASE Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is derived from the principal activity of the company which is that of plastic surgery services. Turnover is recognised when the company becomes entitled to it.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 33% on cost
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 April 2022
and 31 March 2023 1,964
AMORTISATION
At 1 April 2022 618
Charge for year 196
At 31 March 2023 814
NET BOOK VALUE
At 31 March 2023 1,150
At 31 March 2022 1,346

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 14,718
Additions 209
At 31 March 2023 14,927
DEPRECIATION
At 1 April 2022 14,608
Charge for year 121
At 31 March 2023 14,729
NET BOOK VALUE
At 31 March 2023 198
At 31 March 2022 110

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 3,820 1,300
Other debtors 211,966 140,716
215,786 142,016

LASE MEDICAL LIMITED (REGISTERED NUMBER: 08019500)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 535 528
Taxation and social security 29,780 20,036
Other creditors 98,251 88,048
128,566 108,612

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
2 Ordinary £1 2 2
1 Class 'A' Redeemable £1 1 1
1 Class 'B' Redeemable £1 1 1
1 Class 'C' Redeemable £1 1 1
5 5

9. RELATED PARTY DISCLOSURES

During the year a director maintained an interest free loan to the company. The balance of £93,977 remained outstanding as at the year end (2022: £85,858).

During the year the company provided loan finance to a company related by common directors /shareholders. This loan is interest free and repayable on demand. At 31 March 2023 the balance of the loan was £210,716 (2022: £140,716). Services of directors and associated costs were recharged by that company on what the directors have assessed as market terms (£30,000, 2021/22 - £30,000).

Included within other creditors is an interest free unsecured amount due to a close relative of a director of £2,000 (2022: £Nil).